We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+3.65%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$2.45B
AUM Growth
+$37.8M
Cap. Flow
-$23.6M
Cap. Flow %
-0.96%
Top 10 Hldgs %
23.64%
Holding
487
New
24
Increased
101
Reduced
204
Closed
19

Top Buys

Rank Stock Value
1
YUMC icon
Yum China
YUMC
+$1.97M
2
SABR icon
Sabre
SABR
+$1.28M
3
NKE icon
Nike
NKE
+$1.07M
4
PSA icon
Public Storage
PSA
+$1.07M
5
SCHW
Charles Schwab
SCHW
+$958K

Top Sells

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$2.39M
2
AGN
Allergan plc
AGN
+$2.11M
3
YUM icon
Yum! Brands
YUM
+$1.79M
4
DELL icon
Dell
DELL
+$1.61M
5
OXY icon
Occidental Petroleum
OXY
+$1.23M

Sector Composition

Rank Sector Weight
1 Healthcare 15.3%
2 Financials 13.11%
3 Consumer Staples 11.73%
4 Industrials 11.45%
5 Technology 10.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KO icon
26
Coca-Cola
KO
$354B
$23.5M 0.96%
565,781
-8,313
-1% -$346K
MDLZ icon
27
Mondelez International
MDLZ
$77.7B
$22.8M 0.93%
514,318
-7,955
-2% -$343K
HON icon
28
Honeywell
HON
$77.1B
$22.6M 0.92%
215,914
-2,171
-1% -$221K
WFC icon
29
Wells Fargo
WFC
$261B
$21.4M 0.87%
388,068
+6,739
+2% +$339K
MRK icon
30
Merck
MRK
$324B
$21.2M 0.87%
378,168
+2,956
+0.8% +$173K
MET icon
31
MetLife
MET
$61B
$21.2M 0.87%
442,136
-9,130
-2% -$419K
NVS icon
32
Novartis
NVS
$295B
$20.7M 0.84%
316,493
-5,392
-2% -$350K
GILD icon
33
Gilead Sciences
GILD
$161B
$20.4M 0.83%
284,641
-15,077
-5% -$1.12M
ASML icon
34
ASML
ASML
$675B
$20.2M 0.82%
179,635
-1,058
-0.6% -$111K
MMM icon
35
3M
MMM
$89B
$20M 0.82%
133,917
-1,055
-0.8% -$152K
OXY icon
36
Occidental Petroleum
OXY
$57B
$19.6M 0.8%
274,968
-17,364
-6% -$1.23M
BRK.B icon
37
Berkshire Hathaway Class B
BRK.B
$1.07T
$19.3M 0.79%
118,625
-3,790
-3% -$584K
DD
38
DELISTED
Du Pont De Nemours E I
DD
$18.6M 0.76%
253,467
-5,765
-2% -$409K
ABT icon
39
Abbott
ABT
$180B
$17.7M 0.72%
461,982
+3,716
+0.8% +$147K
QCOM icon
40
Qualcomm
QCOM
$176B
$16.8M 0.68%
256,912
-591
-0.2% -$39.7K
META icon
41
Meta Platforms (Facebook)
META
$1.51T
$16.7M 0.68%
145,351
+5,176
+4% +$636K
MA icon
42
Mastercard
MA
$477B
$16.4M 0.67%
158,781
-785
-0.5% -$81.3K
PFE icon
43
Pfizer
PFE
$140B
$16.2M 0.66%
526,178
-1,295
-0.2% -$39.5K
NKE icon
44
Nike
NKE
$61.9B
$16.2M 0.66%
318,486
+20,824
+7% +$1.07M
GOOGL icon
45
Alphabet (Google) Class A
GOOGL
$3.91T
$16M 0.66%
404,940
-1,500
-0.4% -$60K
NXPI icon
46
NXP Semiconductors
NXPI
$68B
$15.9M 0.65%
162,225
-2,207
-1% -$219K
ZTS icon
47
Zoetis
ZTS
$31.6B
$15.8M 0.64%
294,896
-3,019
-1% -$153K
DHR icon
48
Danaher
DHR
$135B
$15.2M 0.62%
220,222
-2,914
-1% -$202K
C icon
49
Citigroup
C
$222B
$15.2M 0.62%
255,171
-4,172
-2% -$225K
AGN
50
DELISTED
Allergan plc
AGN
$14.9M 0.61%
70,758
-10,194
-13% -$2.11M

Similar funds

Gofen & Glossberg's Q4 2016 Portfolio in Review

As of Q4 2016, Gofen & Glossberg held 487 positions worth $2.45B, up 1.6% from $2.41B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Gofen & Glossberg's Q4 2016 filing shows 24 new, 101 increased, 204 reduced and 19 closed positions. Its largest new stake was Yum China: 72,544 shares worth $1.9M. The largest sale was Perrigo, an estimated $2.39M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Staples.

  • Gofen & Glossberg's largest Q4 2016 buy was Yum China: 72,544 shares worth $1.9M.
  • Gofen & Glossberg added most to Nike in Q4 2016, an estimated $1.07M increase.
  • Gofen & Glossberg's biggest Q4 2016 reduction was Perrigo, cutting an estimated $2.39M.
  • Gofen & Glossberg fully exited Fleetmatics Group PLC in Q4 2016, selling an estimated $337K.
  • Gofen & Glossberg's ten largest holdings make up 24% of its $2.45B portfolio in Q4 2016.
  • Gofen & Glossberg opened 24 new positions and closed 19 in Q4 2016.
  • Gofen & Glossberg's portfolio value rose 1.6% quarter-over-quarter to $2.45B.

Based on Gofen & Glossberg's 13F filing for Q4 2016, filed 18 Jan 2017.